Minatullah Al-Ani

Dr. Minatullah Al-Ani

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
MAMinatullah Al-Ani
Minatullah Al-Ani
YAYassir Al-Ani
Yassir Al-Ani
SIShahad Sabaawi Ibrahim
Shahad Sabaawi Ibrahim
RIRaghad Sabaawi Ibrahim
Raghad Sabaawi Ibrahim
Peter KubatkaPeter Kubatka
Peter Kubatka
Dietrich BüsselbergDietrich Büsselberg
Dietrich Büsselberg
Bisphenol A (BPA), a synthetic industrial compound widely found in plastics and other materials, has been linked to cancer development. As human exposure increases, BPA may pose potential carcinogenic concerns. Although BPA binds to estrogen receptors with much lower affinity than natural estrogens, its accumulation in human tissues can cause harmful effects. This review summarizes current evidence on BPA’s role in cancer initiation and progression, with a focus on its effects on cancer signaling pathways. These effects involve modulating pathways involved in cell growth, movement, invasion, survival, and adhesion. BPA acts as an estrogen ligand, binding to estrogen receptors and activating related pathways. The main route of exposure is through dietary intake of canned and plastic-packaged foods, with migration rates increasing at higher temperatures. To raise awareness of BPA’s harmful effects, industries have proposed “BPA-free” alternatives, some of which use derivatives like bisphenol S (BPS) and bisphenol F (BPF), which, unfortunately, may have even worse effects on human health. Given the ongoing challenges of eliminating BPA and similar harmful compounds, future research should focus on identifying safe substitutes, developing more effective removal technologies, and strengthening stringent regulations to mitigate public health risks.

28 April 2026 in Tomography
Verified
Journal Article
Open access
PDF file
SAShahd Aljoudi
Shahd Aljoudi
AKAasiya Khan
Aasiya Khan
IDIman Dajani
Iman Dajani
MAMinatullah Al-Ani
Minatullah Al-Ani
MMMichael Mina
Michael Mina
MYMohammad Yousef
Mohammad Yousef
Background/Objectives: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men globally. Radiation oncologists often find PCa tumor characterization and outcome prediction challenging. Therefore, the potential for artificial intelligence (AI) implementation in radiation oncology has increased in recent years. This systematic review aims to evaluate the efficacy of AI algorithms in characterizing PCa tumors and predicting post-therapy outcomes. Methods: A total of 2055 studies were identified through a comprehensive search across PubMed and Scopus, then exported to Covidence. Inclusion criteria focused on prospective and retrospective cohort studies as well as randomized clinical trials (RCTs) published between 2015 and 2024 that explored the implementation of AI in tumor characterization and outcome prediction of PCa. Two independent reviewers evaluated each paper, and evaluation metrics such as specificity, sensitivity, accuracy, and area under the curve (AUC) were analyzed. The Risk of Bias in Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) tool was used to assess the risk of bias (ROB). Results: Across the 19 studies analyzed, there was no significant difference in model performance between machine learning (ML) and deep learning (DL) models. AI models using multi-input strategies (e.g., radiomics with clinical markers) generally performed better than single-input models. Of the imaging modalities used for radiomic feature extraction, multiparametric MRI (mpMRI)-trained AI models consistently achieved the highest performance. Conclusions: AI displays considerable potential for integration into clinical workflows for PCa management. However, further studies utilizing larger datasets and external cohorts independent of the sample population are needed to validate clinical utility and improve model transparency for reliable implementation.

20 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
HZHadeel Zaghloul
Hadeel Zaghloul
BABatoul Arabi
Batoul Arabi
MAMinatullah Al-Ani
Minatullah Al-Ani
AAAya Abdullah
Aya Abdullah
REReel El-Masri
Reel El-Masri
TAThurayya Arayssi
Thurayya Arayssi
Whether diverse populations outside Western settings are behaviourally ready to integrate wearable-derived data into clinical care remains poorly understood. This study examines sociotechnical determinants of wearable adoption and digital health data-sharing readiness in a large, highly diverse multinational population in Qatar, a rapidly digitising health ecosystem with advanced eHealth infrastructure. We conducted a cross-sectional community-based survey of 3,004 adults across Qatar, assessing wearable device use, behavioural engagement, and willingness to integrate wearable-generated data into healthcare workflows. Multivariable logistic regression identified independent predictors of wearable adoption. Wearable device use prevalence was 34.1%. Behavioural factors were the strongest independent predictors of adoption: daily exercisers had more than four times the odds of wearable use compared with rarely active participants, and willingness to share data with healthcare providers was independently associated with adoption after full adjustment. Notably, education level was not independently associated with wearable use, suggesting that behavioural readiness outweighs traditional socioeconomic indicators as a determinant of digital health engagement. Older age (≥56 years) and African ethnicity were associated with lower adoption odds, highlighting persistent digital inequities. These findings challenge the assumption that digital health equity is primarily an education or access problem, repositioning it as a behavioural engagement challenge. Health systems scaling remote monitoring programmes should prioritise identifying behaviourally engaged subpopulations rather than relying solely on demographic targeting. Targeted digital engagement strategies addressing older adults and underrepresented ethnic groups are essential for equitable implementation of digital medicine. Author Summary: Wearable health devices - such as fitness trackers and smartwatches - are increasingly being considered not just as consumer gadgets but as tools that could help doctors monitor patients continuously between clinic visits. For this to work at a population level, we need to understand who is actually using these devices and why. Most research on this question has come from Western countries, leaving large gaps in our understanding of more diverse, rapidly developing health systems. We surveyed 3,004 adults living in Qatar, one of the most culturally and linguistically diverse countries in the world, and found that about one in three people already uses a wearable health device. More importantly, we found that the strongest predictors of who uses these devices were not education level or socioeconomic status, as is commonly assumed, but rather behavioural factors: how often someone exercises, and whether they are willing to share their device data with a doctor. Daily exercisers were more than four times as likely to use a wearable compared with rarely active individuals, and education level made no difference once we accounted for these behavioural factors. These findings suggest that efforts to expand the use of digital health tools should focus on identifying and engaging people who are already motivated about their health, rather than assuming that technology training alone will drive adoption. At the same time, older adults and African participants used wearables less often, a reminder that targeted and culturally sensitive approaches remain essential for health equity.